This Pharma Company Is Working With The Israeli Medical Center To Research And Treat Autism With CBD – SciSparc (NASDAQ:SPRC)

Cyspark Limited SPRCA pharmaceutical company focused on the development of therapies to treat disorders of the central nervous system, announced that it has signed an agreement with Soroka University Medical Center, located in Beer-Sheva, Israel.

what’s it about?

SciSparc, along with the Medical Center, aims to conduct a clinical study for SCI-210 in patients suffering from Autism Spectrum Disorder (ASD).

In addition, “the trial will examine the efficacy and safety of Cyspark’s drug candidate SCI-210, a proprietary combination of cannabidiol and cannamide, compared to CBD monotherapy in the treatment of ASD.” reads Press release.

“The signing of the agreement with Soroka Medical Center represents another step toward starting our clinical trials in ASD,” said Oz Adler, CEO of Cyspark. “The trial in ASD strengthens the company’s advanced clinical programs, as well as our Phase IIb clinical trials for SCI-110 in patients with Tourette syndrome and SCI-110 in patients with Alzheimer’s disease and agitation. IIa clinical trial.”

The study focused on evaluating the safety, tolerability, and efficacy of SCI-210 in children with ASD in a randomized, double-blind, placebo-controlled cross-over study. ASD is a condition related to brain development that affects how a person interacts with others and causes problems with social interaction and communication. in the word ‘spectrum’ autism spectrum disorder Refers to a wide range of symptoms and severity.

The study design consisted of a 20-week randomized double-blind placebo-controlled cross-over clinical trial of 60 children.

The trial has three primary efficacy endpoints:

  • Aberrant Behavior Checklist-Community (ABC-C) Parent Questionnaire;
  • Clinical Global Impressions-Improvement (CGI-I) is administered by a physician; And
  • effective therapeutic dose.

background: To conduct the clinical trial, Cyspark received approval from the Israeli Ministry of Health as well as the Ethics Committee of the Soroka University Medical Center in 2022.

“We are honored to collaborate with Soroka Medical Center, a leading medical center in Israel, co-founder and partner of the Israeli National Center for Autism and Neurodevelopment Research, which is committed to innovation in translational research, diagnosis, and intervention. is a leading international center for ASD and other neurodevelopmental conditions,” Adler said. “The Soroka Medical Center is another example of our continued efforts to cooperate with the world’s leading medical institutions.”

Israeli researchers discover benefits of THC for autism

majority of studies A focus on the use of cannabis to treat symptoms of autism highlights the benefits of CBD.

However, researchers at Tel Aviv University have discovered that the psychoactive compound THC may actually be more useful. Researcher Shani Poleg told the Times of Israel, “The studies that are underway mostly don’t focus enough on what’s in cannabis that might help people.” “In our study, we looked at the details and made surprising and interesting findings.”

get your daily dose of cannabis news Benzinga on Cannabis. Don’t miss out on any important developments in the industry.

Photo: Courtesy Annie Spratt On unsplash

Source link

Leave a Comment